JARUL AS AN ANTI DIABETIC DRUG
Phase 2
- Conditions
- Health Condition 1: E089- Diabetes mellitus due to underlying condition without complicationsHealth Condition 2: E139- Other specified diabetes mellituswithout complications
- Registration Number
- CTRI/2021/09/036516
- Lead Sponsor
- Priyanka khantwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Fasting blood glucose level >1l0& upto <200mg/dl
2. Post Prandial blood sugar level >140 &
upto <300mg/dl
3. Patients between the age group of 20-60 years
irrespective of gender.
4. Patients of either sex will be taken.
Exclusion Criteria
1.Patients of Type1 diabetes mellitus.
2.Age below 20 years & above 60 years.
3.Blood sugar-fasting Blood sugar level >200mg/dl
4.Post Prandial blood sugar level >300mg/dl
5.Patient having complication.
6.Other serious medical & surgical ill patient will be excluded
7.Patient cannot follow the dietary regime.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in symptoms of Excessive urination (polyuria) <br/ ><br>â?¢ Turbidity in urine <br/ ><br>â?¢Excessive Hunger (Polyphagia) <br/ ><br>â?¢ Excessive thirst (Polydipsia) <br/ ><br>â?¢Burning sensation of hands and feet <br/ ><br>â?¢ Debility <br/ ><br>â?¢ Weakness <br/ ><br>â?¢ Weight loss <br/ ><br>Timepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method Improvement in Blood Sugar Fasting and post-Prandial <br/ ><br>Bodyweight and B.M.I, <br/ ><br>Timepoint: 12 weeks